Follow
Henry Jensen
Henry Jensen
Other namesH Jensen
Research Unit for General Practice, Aarhus University
Verified email at feap.dk - Homepage
Title
Cited by
Cited by
Year
Cancer suspicion in general practice, urgent referral and time to diagnosis: a population-based GP survey and registry study
H Jensen, ML Tørring, F Olesen, J Overgaard, P Vedsted
BMC cancer 14, 1-11, 2014
1552014
Diagnostic intervals before and after implementation of cancer patient pathways–a GP survey and registry based comparison of three cohorts of cancer patients
H Jensen, ML Tørring, F Olesen, J Overgaard, M Fenger-Grøn, P Vedsted
BMC cancer 15, 1-10, 2015
942015
Rural–urban disparities in time to diagnosis and treatment for colorectal and breast cancer
RJ Bergin, J Emery, RC Bollard, AZ Falborg, H Jensen, D Weller, ...
Cancer Epidemiology, Biomarkers & Prevention 27 (9), 1036-1046, 2018
692018
Advanced‐stage cancer and time to diagnosis: an international cancer benchmarking partnership (ICBP) cross‐sectional study
ML Tørring, AZ Falborg, H Jensen, RD Neal, D Weller, I Reguilon, ...
European Journal of Cancer Care 28 (5), e13100, 2019
602019
Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer …
D Weller, U Menon, AZ Falborg, H Jensen, A Barisic, AK Knudsen, ...
BMJ open 8 (11), e023870, 2018
552018
Prognostic consequences of implementing cancer patient pathways in Denmark: a comparative cohort study of symptomatic cancer patients in primary care
H Jensen, ML Tørring, P Vedsted
BMC cancer 17, 1-10, 2017
502017
An investigation of routes to cancer diagnosis in 10 international jurisdictions, as part of the International Cancer Benchmarking Partnership: survey development and …
D Weller, P Vedsted, C Anandan, A Zalounina, EO Fourkala, R Desai, ...
BMJ open 6 (7), e009641, 2016
442016
Quality deviations in cancer diagnosis: prevalence and time to diagnosis in general practice
H Jensen, A Nissen, P Vedsted
British Journal of General Practice 64 (619), e92-e98, 2014
432014
Variation in the initial assessment and investigation for ovarian cancer in symptomatic women: a systematic review of international guidelines
G Funston, M Van Melle, MLL Baun, H Jensen, C Helsper, J Emery, ...
BMC cancer 19, 1-13, 2019
332019
The effect of standardised cancer pathways on Danish cancer patients' dissatisfaction with waiting time
TL Dahl, P Vedsted, H Jensen
Dan Med J 64 (1), A5322, 2017
322017
The role of general practice in routes to diagnosis of lung cancer in Denmark: a population-based study of general practice involvement, diagnostic activity and diagnostic …
LM Guldbrandt, M Fenger-Grøn, TR Rasmussen, H Jensen, P Vedsted
BMC Health Services Research 15, 1-10, 2015
322015
Existing data sources for clinical epidemiology: Danish Cancer in Primary Care cohort
H Jensen, ML Tørring, MB Larsen, P Vedsted
Clinical Epidemiology, 237-246, 2014
322014
A primary healthcare-based intervention to improve a Danish cervical cancer screening programme: a cluster randomised controlled trial
H Jensen, H Svanholm, H Stoevring, F Bro
Journal of Epidemiology & Community Health 63 (7), 510-515, 2009
312009
Identification of patients with incident cancers using administrative registry data
MB Larsen, H Jensen, RP Hansen, F Olesen, P Vedsted
Dan Med J 61 (2), A4777, 2014
272014
Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP)
U Menon, P Vedsted, AZ Falborg, H Jensen, S Harrison, I Reguilon, ...
BMJ open 9 (11), e025895, 2019
262019
Consultation frequency in general practice before cancer diagnosis in relation to the patient’s usual consultation pattern: a population-based study
H Jensen, P Vedsted, H Møller
Cancer epidemiology 55, 142-148, 2018
242018
Current organisation of follow-up does not meet cancer patients' needs
C Sperling, M Sandager, H Jensen, JL Knudsen
Dan Med J 61 (6), A4855, 2014
222014
Time from incident primary cancer until recurrence or second primary cancer: risk factors and impact in general practice
LA Rasmussen, H Jensen, LF Virgilsen, AZ Falborg, H Møller, P Vedsted
European journal of cancer care 28 (5), e13123, 2019
192019
Cancer patients’ experiences with urgent referrals to cancer patient pathways
M Sandager, H Jensen, H Lipczak, CD Sperling, P Vedsted
European journal of cancer care 28 (1), e12927, 2019
192019
Exploration of the possible effect on survival of lead-time associated with implementation of cancer patient pathways among symptomatic first-time cancer patients in Denmark
H Jensen, P Vedsted
Cancer epidemiology 49, 195-201, 2017
192017
The system can't perform the operation now. Try again later.
Articles 1–20